Stay updated on Benralizumab in Eosinophilic CRSwNP Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Eosinophilic CRSwNP Clinical Trial page.

Latest updates to the Benralizumab in Eosinophilic CRSwNP Clinical Trial page
- Check3 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedA sitewide NIH banner announces updates and FAQs about the terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check17 days agoChange DetectedThe site footer revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedThe ClinicalTrials.gov page footer shows revision v3.7.1 instead of v3.7.0, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check45 days agoChange DetectedAccess to the NCT04157335 study details is blocked by a 403 Forbidden page, replacing the study record content with an access-denied screen. The page still shows the site header and navigation, but the actual trial information is no longer accessible.SummaryDifference17%

- Check66 days agoChange DetectedA new NIH grant/contract line was added to the study identifiers, and the revision history now shows a new page revision (v3.6.6) with the previous revision (v3.6.5) removed.SummaryDifference0.1%

Stay in the know with updates to Benralizumab in Eosinophilic CRSwNP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Eosinophilic CRSwNP Clinical Trial page.